Midlife C-reactive protein and risk of cognitive decline: A 31-year follow-up

Neurobiology of Aging

Volumn 30, Issue 11, 2009, Pages 1724-1727

  Laurin, Danielle ^a,c   David Curb, J ^b   Masaki, Kamal H ^b   White, Lon R ^b   Launer, Lenore J ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b KUAKINI MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

C reactive protein; Cognition; Longitudinal studies

Indexed keywords

APOLIPOPROTEIN E4; C REACTIVE PROTEIN;

AGED; ARTICLE; ASIAN AMERICAN; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ASIAN AMERICANS; C-REACTIVE PROTEIN; COGNITION DISORDERS; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS;

EID: 70249134659     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.01.008     Document Type: Article

References (16)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. revised (1987), American Psychiatric Association, Washington, DC
2. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 (1992) 473-480
3. Curb J.D., Abbott R.D., Rodriguez B.L., Sakkinen P., Popper J.S., Yano K., and Tracy R.P. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107 (2003) 2016-2020
4. Dik M.G., Jonker C., Hack C.E., Smit J.H., Comijs H.C., and Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64 (2005) 1371-1377
5. Eiriksdottir G., Aspelund T., Bjarnadottir K., Olafsdottir E., Gudnason V., Launer L.J., and Harris T.B. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis 186 (2006) 222-224
6. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43 (1997) 52-58
7. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
8. Peila R., and Launer L.J. Inflammation and dementia: epidemiologic evidence. Acta Neurol. Scand. 185 Suppl. (2006) 102-106
9. Ridker P.M. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am. Heart J. 148 (2004) S19-S26
10. Schmidt R., Schmidt H., Curb J., Masaki K., White L.R., and Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 52 (2002) 168-174
11. Teng E.L., Hasegawa K., Homma A., Imai Y., Larson E., Graves A., Sugimoto K., Yamaguchi T., Sasaki H., Chiu D., and White L.R. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int. Psychogeriatr. 6 (1994) 45-58 (discussion 62)
12. Weaver J., Huang M., Albert M., Harris T., Rowe J.W., and Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59 (2002) 371-378
13. Weuve J., Ridker P.M., Cook N.R., Buring J.E., and Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 17 (2006) 183-189
14. White L., Petrovitch H., Ross G., Masaki K.H., Abbott R.D., Teng E.L., Rodriguez B.L., Blanchette P.L., Havlik R.J., Wergowske G., Chiu D., Foley D.J., Murdaugh C., and Curb J.D. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA 276 (1996) 955-960
15. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B., Penninx B.W., Pahor M., Kritchevsky S., Launer L., Kuller L., and Rubin S. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 (2004) 2237-2242
16. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., Launer L., Kuller L., Rubin S., and Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80